PROJECT ACT
Live / Applied — Final refusal mailed (as of 08 Oct 2025)
What this means for you
Not registered yet, but its 06 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98889788
- Mark type
- Stylized text
- Filed
- 06 Dec 2024
- Attorney of record
- Emily R. Billig
Goods and services
- Class 042 — Scientific and technological services: Providing information about medical research; providing information about medical research in the field of type 1 diabetes; Providing information about medical and scientific research via a website; Providing medical and scientific research information in the field of clinical trials; Medical and scientific research services, namely, conducting clinical trials for others, namely, developing guidelines for clinical trial models and endpoints
Owner
- Breakthrough T1D, New York, NY, US
Prosecution history
- 08 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 08 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 08 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 08 Oct 2025 — FINAL REFUSAL E-MAILED
- 08 Oct 2025 — FINAL REFUSAL WRITTEN
- 24 Sept 2025 — DIVISIONAL PROCESSING COMPLETE
- 05 Sept 2025 — DIVISIONAL REQUEST RECEIVED
- 23 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Sept 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 05 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Jun 2025 — NON-FINAL ACTION E-MAILED
- 05 Jun 2025 — NON-FINAL ACTION WRITTEN